AFM
Anson Funds Management’s SELLAS Life Sciences SLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $602K | Sell |
275,000
-7,304,095
| -96% | -$16M | 0.09% | 74 |
|
|
2025
Q1 | $8.19M | Buy |
7,579,095
+6,386,829
| +536% | +$6.9M | 1.49% | 14 |
|
|
2024
Q4 | $1.24M | Buy |
1,192,266
+398,431
| +50% | +$414K | 0.13% | 63 |
|
|
2024
Q3 | $992K | Buy |
+793,835
| New | +$992K | 0.1% | 89 |
|
|
2024
Q2 | – | Sell |
-4,832,368
| Closed | -$4.88M | – | 174 |
|
|
2024
Q1 | $4.88M | Buy |
+4,832,368
| New | +$4.88M | 0.32% | 25 |
|
|
2019
Q3 | – | Sell |
-463,756
| Closed | -$52 | – | 46 |
|
|
2019
Q2 | $52 | Buy |
+463,756
| New | +$52 | 0.03% | 33 |
|